This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Miravant Medical Technologies
Drug Names(s): PhotoPoint MV9411
Description: PhotoPoint MV9411 utilizes Miravant's proprietary Photodynamic therapy (PDT). PhotoPoint MV9411 is a drug in a topical gel formulation designed to efficiently penetrate the skin, that is activated by PDT.
In the two-step investigational procedure, varying doses of PhotoPoint MV9411 are applied directly to psoriatic plaques followed by a light treatment. PhotoPoint Targets Rapidly Proliferating Skin Cells.
PhotoPoint MV9411 News
Additional information available to subscribers only: